"The use of PBPK modelling replaces simplistic tools like BCS/DCS classification, that oversimplify the challenges in bringing a molecule to the clinic". Catalent's Stephen Tindal discusses the use of #PBPKmodelling to tackle bioavailability and solubility issues in this Drug Development & Delivery article: https://ow.ly/5sM550VuKXJ
关于我们
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com. Catalyst + Talent. Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. We have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging results. more products. better treatments. reliably supplied.™ Your talents, ideas, and passion are essential to our mission: to develop, manufacture, and supply products that help people live better, healthier lives. Join us! Catalent hires people with a passion to make a difference to the health of millions of people globally. Your expertise, coupled with Catalent’s advanced technologies and collaboration with thousands of innovative pharmaceutical, biotech, and healthcare companies, will help bring life-enhancing products to life. Grow with us. Be challenged. Make a personal impact.
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Somerset，NJ
- 类型
- 上市公司
- 领域
- Analytical Chemistry、Clinical Supply、Biotech、Pharmaceutical Supply Chain、Biologics、Formulation Development、Drug Delivery、Clinical Packaging、Dose Form Manufacturing、Gene Therapy、Vaccine Production、Pharmaceutical、Drug Development、Cell Therapy、Biopharmaceutical和Innovation
地点
Catalent员工
-
Chris "Cpat" Patteson 🤠
Manufacturing Risk Management / Cybersecurity Executive | Cyber Governance, Risk Management, Compliance, Strategy, and Resiliency Leadership | NOLA…
-
Robert Forsythe, CPA, MBA
Financial Executive | Senior Director | Financial Reporting and Accounting Leader | Internal/External (SEC) Reporting | General Ledger Closes |…
-
M. Brandon Means
-
Charles Lickfold
Senior Vice President, Chief Technology Officer at Catalent Pharma Solutions
动态
-
Join us at in-cosmetics Global 2025! Innovation meets protection with every CosmoPod® capsule. At in-cosmetics® global, we’re showcasing how CosmoPod® capsules provide unmatched precision, consistency, and protection for beauty formulations. Designed to shield from degradation, maintain integrity, and eliminate waste, CosmoPod® is the future of skincare encapsulation! Don’t miss the opportunity to explore CosmoPod® capsules. Schedule your meeting today: https://ow.ly/gpqK50Vu0LQ #CosmoPod #inCosmeticsGlobal #BeautyInnovation #Encapsulation #Skincare #SustainableBeauty
-
-
Exciting news! It's the grand opening of our new Sample Management Office! 📢 Fully dedicated to our Biologics Analytical Services, this investment is another example of our commitment to customer dedication. Here’s how this can benefit you: ✅Improve workflows for better traceability ✅Double sample management capacity with a focus on ultracold conditions ✅Meet your urgent expectations with dedication and extra care ✅Enhanced protection for your temperature sensitive samples Learn more about our capabilities: https://ow.ly/bN0650VsuWI #AnalyticalServices #BiologicalSamples #SampleManagement
-
-
Join Catalent at GCSG 2025! Explore our comprehensive clinical supply services, supporting trials worldwide. Visit us at our booth and join in on insightful sessions as we delve into key supply chain management topics, including the role of specialty pharmacies in decentralized trials, how to navigate complexities in cell and gene therapy supply, and the importance of enhancing communication across sponsors, CROs, and clinical teams. Don’t forget to unwind with us at the "Texas Road Trip" Meet & Greet on Sunday evening, co-sponsored by Catalent. It’s the perfect mix of fun and networking with industry leaders! Schedule a meeting with our experts: https://ow.ly/bhWs50VrsJH #GCSG2025 #Networking #ClinicalSupplyChain
-
-
We are proud to celebrate our 8th annual #EarthMonth! Throughout April, Green Teams across our global network are driving personal and collective action to tackle plastic waste and minimize the environmental footprint of our sites and local communities. Stay tuned to see our global team in full #EarthMonth action, protecting our planet for today and tomorrow!🌍 #EnvironmentalSustainability #CorporateResponsibility #CatalentCares
-
Catalent is excited to announce our participation at Meeting on the Med 2025! Join us to engage with our leading Cell and Gene Therapy experts and discover how Catalent’s integrated offerings can accelerate your therapy programs. Don’t miss insightful presentations from our team. Frederic Cedrone will delve into our strategic iPSC partnership model, and Nirupama (Rupa) Pike will moderate a vital panel on 'Expanding Access to CAR-T Therapies: Overcoming Barriers and Driving Adoption'. We look forward to exploring collaboration opportunities that advance the field and bring innovative treatments to market faster! Schedule a meeting with our experts: https://ow.ly/fWWU50VqjSM #MeetingOnTheMed2025 #CellGeneTherapy #CatalentPharma
-
-
Discover Catalent's GPEx® Lightning Technology Platform! Explore our latest white paper on how GPEx® Lightning cell line development technology revolutionizes biologics manufacturing. This scalable platform ensures high-expressing, stable production across a spectrum of biologic types, including multi-specific and difficult to express proteins. 🔍 Key Highlights: 🔹Enhanced production efficiency. 🔹Tunable expression for complex proteins. 🔹Flexibility for next-gen biologics. Learn how our technology can support your biopharmaceutical projects: https://ow.ly/10Ph50VpJF1 #BiologicsDevelopment #CellLineDevelopment #Catalent #Innovation
-
-
We’re delighted and proud that Catalent’s Brandon Pena has been selected as a BSMA 40 Under Forty Award winner! This prestigious recognition celebrates Brandon’s exceptional leadership and significant contributions to the Life Science Supply Chain Management industry. Bio Supply Management Alliance (BSMA) supports continuous learning and improvement of bio supply management professionals and the enhancement of the efficacy of the supply chain of the industry through collaboration. Congratulations, Brandon! #biosupply #lifescience #supplychain
-
-
Check out our very own Nirupama (Rupa) Pike as she discusses the critical role of advanced analytics in revolutionizing cell therapy production. Learn why flexibility is key to success and how Catalent can help you achieve your goals! #CatalentInnovation #CellTherapy #AdvancedTherapies
🔢 At the Catalent Pharma Solutions booth on the Advanced Therapies show floor, Nirupama (Rupa) Pike discusses the role of data-driven manufacturing, with the inclusion of advanced analytics, to improve cell therapy manufacturing. 🍪 Rupa goes on to highlight how 'cookie cutter' approaches don't work in this space, and the importance of flexible approaches to cell therapy manufacturing. ▶️ Watch the interview below, or catch up on the full series as more news and insights are added, here: https://lnkd.in/eVnfPQVB #CellTherapy #Manufacturing #Data #AdvancedTherapies #AdvancedAnalytics #AdTherapies Terrapinn
-
Our new white paper on UpTempo℠ Plasmid DNA Platform explores how this innovative, single-use technology is revolutionizing cell and gene therapy manufacturing. From hundreds of milligrams to substantial grams in a single GMP batch, learn how our scalable solutions streamline CGT development and production! 🔬 Key Highlights: 🔹Robust process compliant with cGMP standards 🔹Optimized steps for fermentation, lysis, and purification 🔹Timelines reduced by 8 to 12 weeks 🔹Pre-qualified analytical assays built into the platform Explore the full potential of the UpTempo℠ plasmid platform in our detailed white paper: https://ow.ly/XV3q50VoLM5 #Biotech #Pharma #GeneTherapy #CellTherapy
-